Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors
A. Prasanth Saraswati(University of Siena), Giuseppe Campiani(University of Siena), Daniela M. Zisterer(Trinity College Dublin), Nicola Relitti(University of Siena), Stefania Butini(University of Siena), Margherita Brindisi(University of Naples Federico II), Sandra Gemma(University of Siena)
Cited by 34
Related Papers
Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance
|Current Medicinal Chemistry|2017|127
Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions
|European Journal of Medicinal Chemistry|2017|119
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases
|Journal of Medicinal Chemistry|2019|115